[Use of carminomycin on adult patients with acute leukemias]. 1977

F E Faĭnshteĭn, and L G Kovaleva, and M V Vakhrusheva, and V G Isaev, and E M Abakumov

The data on the clinical trials of karminomycin, a new antitumor antibiotic are presented. The drug was used in the treatment of 46 adult patients with leukemia. Karminomycin was used in primary inducing therapy and treatment of relapses. The results of the trials showed that karminomycin had a definite therapeutic activity in treatment of acute myeloblast leukemia at various stages of the process. A rapid effect of the antibiotic provided its use in emergency cases with rapidly progressing variants of the disease.

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002360 Carubicin A very toxic anthracycline-type antineoplastic related to DAUNORUBICIN, obtained from Actinomadura carminata. Carminomycin,Karminomycin,Carminomicin,Carminomycin I,Carminomycin II,Carminomycin III,Carubicin Hydrochloride,Demethyldaunomycin,Demethyldaunorubicin,Karminomicin,NSC-180,024,NSC-180024,Rubeomycin A,Rubeomycin A1,Hydrochloride, Carubicin,NSC 180,024,NSC 180024,NSC180,024,NSC180024
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic

Related Publications

F E Faĭnshteĭn, and L G Kovaleva, and M V Vakhrusheva, and V G Isaev, and E M Abakumov
July 1980, Problemy gematologii i perelivaniia krovi,
F E Faĭnshteĭn, and L G Kovaleva, and M V Vakhrusheva, and V G Isaev, and E M Abakumov
August 1982, Antibiotiki,
F E Faĭnshteĭn, and L G Kovaleva, and M V Vakhrusheva, and V G Isaev, and E M Abakumov
July 1980, The Medical clinics of North America,
F E Faĭnshteĭn, and L G Kovaleva, and M V Vakhrusheva, and V G Isaev, and E M Abakumov
November 2023, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
F E Faĭnshteĭn, and L G Kovaleva, and M V Vakhrusheva, and V G Isaev, and E M Abakumov
September 1978, Antibiotiki,
F E Faĭnshteĭn, and L G Kovaleva, and M V Vakhrusheva, and V G Isaev, and E M Abakumov
December 1981, Cancer genetics and cytogenetics,
F E Faĭnshteĭn, and L G Kovaleva, and M V Vakhrusheva, and V G Isaev, and E M Abakumov
April 1975, Blood,
F E Faĭnshteĭn, and L G Kovaleva, and M V Vakhrusheva, and V G Isaev, and E M Abakumov
February 1999, La Revue du praticien,
F E Faĭnshteĭn, and L G Kovaleva, and M V Vakhrusheva, and V G Isaev, and E M Abakumov
February 1979, Antibiotiki,
F E Faĭnshteĭn, and L G Kovaleva, and M V Vakhrusheva, and V G Isaev, and E M Abakumov
January 2015, Terapevticheskii arkhiv,
Copied contents to your clipboard!